BERLIN (EGMN) - Men treated with endocrine therapy for prostate cancer are at increased risk of developing and dying from several types of cardiovascular disease, according to a large observational analysis of 30,642 Swedish patients.When prostate cancer patients were compared with the general Swedish population, the patients' relative risk for having a nonfatal myocardial infarction increased by 24%; their risk increased by 19% for arrhythmia, 31% for ischemic heart disease, and 26% for heart failure....